Diversified Energy Company plc
SC 13G – Schedule filed to report acquisition of beneficial ownership[...]
X4 Pharmaceuticals Announces FDA Approval of XOLREMDI™ (mavorixafor)[...]
Transporeon's Latest Report Reveals Shipper and Carrier Perspectives on[...]
10/26/2023 | Press release | Distributed by Public on 10/27/2023 02:22
Please select the service you want to use:
Smartlinks | The eRulemaking Program | News | Environment | Renewable and Alternative Energy | Environmental Policy | Health | Healthcare Policy | Science | Politics and Policy | Healthcare Policy | Environmental Policy | Policy and Regulation | Government | National Government | Finance | Energy Markets | Commodities | Energy | Energy Markets | Renewable and Alternative Energy | Renewable Energy Industry | Government Agencies
Copyright ©2006-2024 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact